|
E1: complainant street address: (b)(6).Based on the available information, this event is deemed to be a reportable malfunction.Photograph, video and/or physical sample evaluation: there were photographs associated with this case and in it, the reported defect can be seen.No unused return sample was expected.Batch record revision results: lot 4f02961 was manufactured on 19/jun/2024, in uhlmann #2 line, with a total of (b)(4) market units (mkus.The complaints investigator performed a batch record review on 16/may/2025, to verify if all the applicable procedures were followed and no issues were found; all the components for assembly were correct per bill of materials (bom) and all the tooling information documented was also correct, system application product (sap) material identification (id) 1704763 and manufacturing order (b)(4).Review of the batch record showed that all relevant tests required during the manufacturing process and final product release had been fulfilled and met the requirements.No discrepancy related to this issue was found within the documentation.The reported malfunction could be generated during the manufacturing process of the final line, therefore no further batch record review of the subassembly lots was required.Historical complaints review: on 16/may/2025, complaints investigator a query in database in order to verify the complaints reported for the 4f02961 lot for the malfunction "foreign matter within product, sterile products (e.G.Metal contamination in dressings, particulates within fluids, gels etc)" defect and no additional complaints were identified.Historical nonconformance review: on 16/may/2025, complaints investigator ran a query in database looking for any in process nonconformance / corrective and preventive actions (capa) (s) associated to the malfunction "foreign matter within product, sterile products (e.G.Metal contamination in dressings, particulates within fluids, gels etc)" defect for the lot number 4f02961 and as result, no nonconformance / capa (s) for this malfunction were generated during the manufacturing process of the referenced lot.Conclusions: as photographs were available for this complaint issue, they were evaluated, and as a result, the reported malfunction for the observed product was confirmed, however, after performing the defect rate analysis for this issue, it was observed that the quantity of reportedly affected products is within the appropriate aql for this defect.A batch record review was completed and showed that all relevant tests required during the manufacturing process and final product release had been fulfilled and met the requirements.No discrepancy related to this issue were found within the documentation.Additionally, no harm was reported due to this complaint issue, and the reported unit wasn't utilized.This issue will be monitored through the post market product monitoring review process, standard operating procedure (sop).To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number.Reporting site: 1049092.Manufacturing site: 9618003.
|